Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
inactivated influenza vaccine (9 trials)
inactivated SARS-Cov-2 vaccine (4 trials)
live-attenuated chikv (1 trial)
live, attenuated, dengue serotype 1, 2, 3, 4 virus (2 trials)
split virion influenza vaccine (1 trial)
COVID-19 convalescent plasma (1 trial)
mpla (1 trial)
ndv-hxp-s (1 trial)
ny-eso-1 (1 trial)
tetravax-dv-tv003 (1 trial)
aluminum hydroxide (Gaviscon) (1 trial)
gla-se (1 trial)
human rotavirus, live attenuated (Rotarix) (1 trial)
ib160 (1 trial)
streptococcus pyogenes (1 trial)
streptococcus pyogenes vaccine (1 trial)
Dengue (Phase 3)
Influenza, Human (Phase 4)
Influenza in Birds (Phase 1)
Melanoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Rheumatic Fever (Phase 1)
Rotavirus Infections (Phase 1)
Trials (22 total)
Trial APIs (16 total)